145 related articles for article (PubMed ID: 32599975)
1. Genome-Wide Association Study for the Identification of Novel Genetic Variants Associated with the Risk of Neuroblastoma in Korean Children.
Bae JS; Lee JW; Yoo JE; Joung JG; Yoo KH; Koo HH; Song YM; Sung KW
Cancer Res Treat; 2020 Oct; 52(4):1251-1261. PubMed ID: 32599975
[TBL] [Abstract][Full Text] [Related]
2. Single nucleotide polymorphism rs11669203 in TGFBR3L is associated with the risk of neuroblastoma in a Chinese population.
Jin Y; Wang H; Han W; Lu J; Chu P; Han S; Ni X; Ning B; Yu D; Guo Y
Tumour Biol; 2016 Mar; 37(3):3739-47. PubMed ID: 26468016
[TBL] [Abstract][Full Text] [Related]
3. Replication of GWAS-identified neuroblastoma risk loci strengthens the role of BARD1 and affirms the cumulative effect of genetic variations on disease susceptibility.
Capasso M; Diskin SJ; Totaro F; Longo L; De Mariano M; Russo R; Cimmino F; Hakonarson H; Tonini GP; Devoto M; Maris JM; Iolascon A
Carcinogenesis; 2013 Mar; 34(3):605-11. PubMed ID: 23222812
[TBL] [Abstract][Full Text] [Related]
4. Candidate Gene Association Analysis of Neuroblastoma in Chinese Children Strengthens the Role of LMO1.
Lu J; Chu P; Wang H; Jin Y; Han S; Han W; Tai J; Guo Y; Ni X
PLoS One; 2015; 10(6):e0127856. PubMed ID: 26030754
[TBL] [Abstract][Full Text] [Related]
5. Identification of GALNT14 as a novel neuroblastoma predisposition gene.
De Mariano M; Gallesio R; Chierici M; Furlanello C; Conte M; Garaventa A; Croce M; Ferrini S; Tonini GP; Longo L
Oncotarget; 2015 Sep; 6(28):26335-46. PubMed ID: 26309160
[TBL] [Abstract][Full Text] [Related]
6. Impact of interleukin-6 -174 G>C gene promoter polymorphism on neuroblastoma.
Totaro F; Cimmino F; Pignataro P; Acierno G; De Mariano M; Longo L; Tonini GP; Iolascon A; Capasso M
PLoS One; 2013; 8(10):e76810. PubMed ID: 24204677
[TBL] [Abstract][Full Text] [Related]
7. WT1 expression is inversely correlated with MYCN amplification or expression and associated with poor survival in non-MYCN-amplified neuroblastoma.
Masserot C; Liu Q; Nguyen E; Gattolliat CH; Valteau-Couanet D; Bénard J; Huber C; Ségal-Bendirdjian E
Mol Oncol; 2016 Feb; 10(2):240-52. PubMed ID: 26482175
[TBL] [Abstract][Full Text] [Related]
8. BLM germline and somatic PKMYT1 and AHCY mutations: Genetic variations beyond MYCN and prognosis in neuroblastoma.
Novak EM; Halley NS; Gimenez TM; Rangel-Santos A; Azambuja AM; Brumatti M; Pereira PL; Vince CS; Giorgi RR; Bendit I; Cristofani LM; Odone-Filho V
Med Hypotheses; 2016 Dec; 97():22-25. PubMed ID: 27876123
[TBL] [Abstract][Full Text] [Related]
9. Genetic variation associated with childhood and adult stature and risk of MYCN-amplified neuroblastoma.
Semmes EC; Shen E; Cohen JL; Zhang C; Wei Q; Hurst JH; Walsh KM
Cancer Med; 2020 Nov; 9(21):8216-8225. PubMed ID: 32945147
[TBL] [Abstract][Full Text] [Related]
10. MIR938 rs2505901 T>C polymorphism is associated with increased neuroblastoma risk in Chinese children.
Jiang S; Sun X; Zhang X; Zhou C; Wu H; He J; Yang W
Biosci Rep; 2023 Nov; 43(11):. PubMed ID: 37905791
[TBL] [Abstract][Full Text] [Related]
11. Association between METTL3 gene polymorphisms and neuroblastoma susceptibility: A nine-centre case-control study.
Bian J; Zhuo Z; Zhu J; Yang Z; Jiao Z; Li Y; Cheng J; Zhou H; Li S; Li L; He J; Liu Y
J Cell Mol Med; 2020 Aug; 24(16):9280-9286. PubMed ID: 32615646
[TBL] [Abstract][Full Text] [Related]
12. A sketch of known and novel MYCN-associated miRNA networks in neuroblastoma.
Megiorni F; Colaiacovo M; Cialfi S; McDowell HP; Guffanti A; Camero S; Felsani A; Losty PD; Pizer B; Shukla R; Cappelli C; Ferrara E; Pizzuti A; Moles A; Dominici C
Oncol Rep; 2017 Jul; 38(1):3-20. PubMed ID: 28586032
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of Genetic Predisposition for MYCN-Amplified Neuroblastoma.
Hungate EA; Applebaum MA; Skol AD; Vaksman Z; Diamond M; McDaniel L; Volchenboum SL; Stranger BE; Maris JM; Diskin SJ; Onel K; Cohn SL
J Natl Cancer Inst; 2017 Oct; 109(10):. PubMed ID: 29117357
[TBL] [Abstract][Full Text] [Related]
14. Polymorphisms of glucose-regulated protein 78 and clinical relevance of neuroblastoma: Risk and prognosis.
Zhang J; Wang J; Liu Q; Gao J; Wang Q
J Cancer Res Ther; 2016; 12(3):1178-1183. PubMed ID: 28054532
[TBL] [Abstract][Full Text] [Related]
15. Common genetic variants associated with telomere length confer risk for neuroblastoma and other childhood cancers.
Walsh KM; Whitehead TP; de Smith AJ; Smirnov IV; Park M; Endicott AA; Francis SS; Codd V; ; Samani NJ; Metayer C; Wiemels JL
Carcinogenesis; 2016 Jun; 37(6):576-582. PubMed ID: 27207662
[TBL] [Abstract][Full Text] [Related]
16. Inherited rare variants in homologous recombination and neurodevelopmental genes are associated with increased risk of neuroblastoma.
Bonfiglio F; Lasorsa VA; Cantalupo S; D'Alterio G; Aievola V; Boccia A; Ardito M; Furini S; Renieri A; Morini M; Stainczyk S; Westermann F; Paolella G; Eva A; Iolascon A; Capasso M
EBioMedicine; 2023 Jan; 87():104395. PubMed ID: 36493725
[TBL] [Abstract][Full Text] [Related]
17.
Li Y; Lu T; Wang J; Zhuo Z; Miao L; Yang Z; Zhang J; Cheng J; Zhou H; Li S; Li L; He J; Li A
Aging (Albany NY); 2021 Dec; 13(23):25426-25439. PubMed ID: 34897032
[TBL] [Abstract][Full Text] [Related]
18. Epithelial-mesenchymal transition-related gene expression as a new prognostic marker for neuroblastoma.
Nozato M; Kaneko S; Nakagawara A; Komuro H
Int J Oncol; 2013 Jan; 42(1):134-40. PubMed ID: 23135478
[TBL] [Abstract][Full Text] [Related]
19. Correlation of modified Shimada classification with MYCN and 1p36 status detected by fluorescence in situ hybridization in neuroblastoma.
Altungoz O; Aygun N; Tumer S; Ozer E; Olgun N; Sakizli M
Cancer Genet Cytogenet; 2007 Jan; 172(2):113-9. PubMed ID: 17213019
[TBL] [Abstract][Full Text] [Related]
20. Epigenome-wide association study reveals CpG sites related to COG of neuroblastoma.
Zhao H; Zhou X; Sun H; Zhao D; Liu H; Huang B; Li X; Gu Y
Biosci Rep; 2020 May; 40(5):. PubMed ID: 32378698
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
